Insight Molecular Diagnostics (IMDX)
Develops molecular diagnostic tests for transplant rejection and oncology therapy programs.
$4.14
After hours+0.03 (+0.73%)
At close$4.11(+2.49%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 56.42% | 18.46M shares | |
|---|---|---|---|
| 41 holders · as of Jun 30, 2026 | |||
| Insiders | 11.54% | 3.78M shares | |
| 7 holders · as of Jul 6, 2026 | |||
| Strategic holders | 123.08% | 40.28M shares | |
| 2 holders · as of Apr 27, 2026 | |||
| Adds to | 191.04% | ||
32.72M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 191.04%; nothing is left for Other.
13F, as of Jun 30, 2026
41 holders · 18.46M shares · 13 new positions · 23 increased · 8 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 12.68M | 38.76% | +753.0K | Aug 14, 2026 |
| Awm Investment Company, Inc. | 2.84M | 8.67% | +30.4K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 735.8K | 2.25% | +198.7K | Aug 13, 2026 |
| Pura Vida Investments, LLC | 484.8K | 1.48% | −462.3K | Aug 13, 2026 |
| Family Office Research LLC | 368.8K | 1.13% | +241.6K | Jul 27, 2026 |
| Geode Capital Management, LLC | 256.9K | 0.79% | −5.2K | Aug 12, 2026 |
| FNY Investment Advisers, LLC | 182.6K | 0.56% | −64.9K | Jul 8, 2026 |
| Jane Street Group, LLC | 157.7K | 0.48% | +157.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Neal C. Bradsherincl. Broadwood Partners, L.P., Broadwood Capital, Inc. | 39.70% | 12.84M | 13D | Apr 27, 2026 |
| AWM Investment Company, Inc. | 10.00% | 2.86M | 13G | May 9, 2025 |
| Bio-Rad Laboratories, Inc | 9.70% | 2.76M | 13G | Mar 4, 2025 |
| Patrick W Smith Ttee the Smith Irrevocable Trust U/A DTD 05/01/2015incl. W. Smith | 6.00% | 1.01M | 13G | Oct 9, 2024 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 23, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 280,381 | $3.50 | 24,790,162 |
| Apr 24, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 38,880 | $3.53 | 24,867,922 |
| Apr 27, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 250,923 | $3.64 | 25,369,768 |
| Apr 16, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 102,057 | $3.45 | 24,067,792 |
| Apr 17, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 40,114 | $3.57 | 24,148,020 |
| Apr 20, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 40,690 | $3.88 | 24,229,400 |
| Feb 10, 2026 | Broadwood Partners, L.P.10 percent owner | Purchase · 2 lots | 521,739 | $5.75 | 23,863,678 |
House and Senate disclosures
Not reported.